Prdx1+/- and Prdx1-/- mice display a range of malignancies including lymphomas, hepatocellular carcinomas, osteosarcomas, islet cell adenomas, and adenocarcinomas of lung and breast 39. Here, PRDX1 is linked to hepatocellular carcinoma.